Patents by Inventor Mary MALLANEY

Mary MALLANEY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230181533
    Abstract: The invention provides formulations comprising a protein in combination with a compound that prevents oxidation of the protein. The invention also provides methods for making such formulations and methods of using such formulations. The invention further provides methods of screening for compounds that prevent oxidation of a protein in a protein composition and methods of preventing oxidation of a protein in a formulation.
    Type: Application
    Filed: February 3, 2023
    Publication date: June 15, 2023
    Inventors: Sreedhara ALAVATTAM, Mary MALLANEY, Parbir GREWAL
  • Patent number: 11596620
    Abstract: The invention provides formulations comprising a protein in combination with a compound that prevents oxidation of the protein. The invention also provides methods for making such formulations and methods of using such formulations. The invention further provides methods of screening for compounds that prevent oxidation of a protein in a protein composition and methods of preventing oxidation of a protein in a formulation.
    Type: Grant
    Filed: November 22, 2017
    Date of Patent: March 7, 2023
    Assignee: F. HOFFMANN-LA ROCHE AG
    Inventors: Sreedhara Alavattam, Mary Mallaney, Parbir Grewal
  • Publication number: 20200354677
    Abstract: The present disclosure provides methods for genetically engineering T cells, such as CD4+ T cells, for use in cell therapy. In some aspects, the provided methods include one or more steps for incubating the cells under stimulating conditions, introducing a recombinant polypeptide to the cells through transduction or transfection, and cultivating the cells under conditions that promote proliferation and/or expansion. In some aspects, the incubation and/or the cultivation is performed in the presence of recombinant IL-2. In some aspects, the provided methods are an efficient, reliable means to produce genetically engineered T cells with a high degree of success.
    Type: Application
    Filed: October 31, 2018
    Publication date: November 12, 2020
    Applicant: Juno Therapeutics, Inc.
    Inventors: Sarah Y. LEE, Pascal BEAUCHESNE, Mark L. BONYHADI, Ryan L. CRISMAN, Ryan P. LARSON, Mary MALLANEY, Christopher Glen RAMSBORG, Clinton WEBER, John Matthew WESNER, Nathan YEE
  • Publication number: 20200191774
    Abstract: Provided herein are methods, compositions and articles of manufacture for use in connection with cell therapy involving the administration of one or more doses of a therapeutic T cell composition. The cells of the T cell composition express recombinant receptors such as chimeric receptors, e.g. chimeric antigen receptors (CARs) or other transgenic receptors such as T cell receptors (TCRs). Features of the provided embodiments, including the numbers of cells or units of cells administered and/or the potency of administered cells, provide various advantages, such as lower risk of toxicity in subjects administered the T cell compositions.
    Type: Application
    Filed: February 27, 2018
    Publication date: June 18, 2020
    Applicant: Juno Therapeutics, Inc.
    Inventors: Brian CHRISTIN, Michael Gerard COVINGTON, Kedar Himanshu DAVE, Richard James GETTO, Jr., Tom KOWSKI, Ryan P. LARSON, Christopher Glen RAMSBORG, Nikolaus Sebastian TREDE, Clinton WEBER, James Boyd WHITMORE, Nathan YEE, Pascal BEAUCHESNE, Travis BECKETT, Samuel Charles BLACKMAN, Nathaniel CHARTRAND, Mel DAVIS-PICKETT, Mark GILBERT, Nathaniel LAMBERT, He LI, Mary MALLANEY, Kathryn Lindsay POLLOCK, Valerie ODEGARD, Jeff SMITH, Claire SUTHERLAND, Andrew W. WALKER
  • Patent number: 10653779
    Abstract: The invention provides formulations comprising a protein in combination with a compound that prevents oxidation of the protein. The invention also provides methods for making such formulations and methods of using such formulations. The invention further provides methods of screening for compounds that prevent oxidation of a protein in a protein composition and methods of preventing oxidation of a protein in a formulation.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: May 19, 2020
    Assignee: GENENTECH, INC.
    Inventors: Sreedhara Alavattam, Mary Mallaney, Parbir Grewal
  • Publication number: 20180318256
    Abstract: The invention provides formulations comprising a protein in combination with a compound that prevents oxidation of the protein. The invention also provides methods for making such formulations and methods of using such formulations. The invention further provides methods of screening for compounds that prevent oxidation of a protein in a protein composition and methods of preventing oxidation of a protein in a formulation.
    Type: Application
    Filed: November 22, 2017
    Publication date: November 8, 2018
    Inventors: Sreedhara ALAVATTAM, Mary MALLANEY, Parbir GREWAL
  • Publication number: 20170196837
    Abstract: The invention provides formulations comprising a protein in combination with a compound that prevents oxidation of the protein. The invention also provides methods for making such formulations and methods of using such formulations. The invention further provides methods of screening for compounds that prevent oxidation of a protein in a protein composition and methods of preventing oxidation of a protein in a formulation.
    Type: Application
    Filed: December 20, 2016
    Publication date: July 13, 2017
    Inventors: Sreedhara ALAVATTAM, Mary MALLANEY, Parbir GREWAL
  • Publication number: 20160108125
    Abstract: The invention provides formulations comprising a protein in combination with a compound that prevents oxidation of the protein. The invention also provides methods for making such formulations and methods of using such formulations. The invention further provides methods of screening for compounds that prevent oxidation of a protein in a protein composition and methods of preventing oxidation of a protein in a formulation.
    Type: Application
    Filed: May 28, 2015
    Publication date: April 21, 2016
    Inventors: Sreedhara ALAVATTAM, Mary MALLANEY, Parbir GREWAL
  • Publication number: 20140322203
    Abstract: The invention provides formulations comprising a protein in combination with a compound that prevents oxidation of the protein. The invention also provides methods for making such formulations and methods of using such formulations. The invention further provides methods of screening for compounds that prevent oxidation of a protein in a protein composition and methods of preventing oxidation of a protein in a formulation.
    Type: Application
    Filed: March 13, 2014
    Publication date: October 30, 2014
    Applicant: GENENTECH, INC.
    Inventors: Sreedhara ALAVATTAM, Mary MALLANEY, Parbir GREWAL
  • Publication number: 20140314778
    Abstract: The invention provides formulations comprising a protein in combination with a compound that prevents oxidation of the protein. The invention also provides methods for making such formulations and methods of using such formulations. The invention further provides methods of screening for compounds that prevent oxidation of a protein in a protein composition and methods of preventing oxidation of a protein in a formulation.
    Type: Application
    Filed: March 13, 2014
    Publication date: October 23, 2014
    Applicant: Genentech, Inc.
    Inventors: Sreedhara ALAVATTAM, Mary MALLANEY, Parbir GREWAL